129 related articles for article (PubMed ID: 38372903)
1. The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
Dasgupta P; Ou A; Lin H; Gregory T; Alfaro-Munoz KD; Yuan Y; Afshar-Khargan V; Kamiya-Matsuoka C; Rousseau JF; Majd NK
J Neurooncol; 2024 Mar; 167(1):181-188. PubMed ID: 38372903
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.
Lee I; Adimadhyam S; Nutescu EA; Zhou J; Asfaw AA; Sweiss KI; Patel PR; Calip GS
Pharmacotherapy; 2019 Sep; 39(9):921-928. PubMed ID: 31332810
[TBL] [Abstract][Full Text] [Related]
3. Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients.
Norden AD; Bartolomeo J; Tanaka S; Drappatz J; Ciampa AS; Doherty LM; Lafrankie DC; Ruland S; Quant EC; Beroukhim R; Wen PY
J Neurooncol; 2012 Jan; 106(1):121-5. PubMed ID: 21706358
[TBL] [Abstract][Full Text] [Related]
4. Clinical and molecular determinants of bleeding-related adverse outcomes in high-grade glioma.
Dasgupta P; Rousseau JF
J Neurooncol; 2024 Feb; 166(3):569-574. PubMed ID: 38286976
[TBL] [Abstract][Full Text] [Related]
5. Safety of bevacizumab in patients with malignant gliomas: a systematic review.
Simonetti G; Trevisan E; Silvani A; Gaviani P; Botturi A; Lamperti E; Beecher D; Bertero L; Bosa C; Salmaggi A
Neurol Sci; 2014 Jan; 35(1):83-9. PubMed ID: 24281944
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Evaluation of Thromboembolism Risk in Ovarian Cancer Patients Treated with Bevacizumab.
Kuk A; Magnowska M; Suchy W; Swierczynska J; Zaborowski MP; Gaca M; Nowak-Markwitz E
Target Oncol; 2017 Aug; 12(4):495-503. PubMed ID: 28580507
[TBL] [Abstract][Full Text] [Related]
7. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
Jo J; Donahue J; Sarai G; Petroni G; Schiff D
Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
[TBL] [Abstract][Full Text] [Related]
8. [Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study].
Guiu S; Taillibert S; Chinot O; Taillandier L; Honnorat J; Dietrich PY; Maire JP; Guillamo JS; Guiu B; Catry-Thomas I; Capelle F; Thiebaut A; Cartalat-Carel S; Deville C; Fumoleau P; Desjardins A; Xuan KH; Chauffert B
Rev Neurol (Paris); 2008; 164(6-7):588-94. PubMed ID: 18565358
[TBL] [Abstract][Full Text] [Related]
9. Management of venous thromboembolism in patients with glioma.
Al Megren M; De Wit C; Al Qahtani M; Le Gal G; Carrier M
Thromb Res; 2017 Aug; 156():105-108. PubMed ID: 28624717
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in high grade glioma among surgical patients: results from a single center over a 10 year period.
Smith TR; Lall RR; Graham RB; Mcclendon J; Lall RR; Nanney AD; Adel JG; Zakarija A; Chandler JP
J Neurooncol; 2014 Nov; 120(2):347-52. PubMed ID: 25062669
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
[TBL] [Abstract][Full Text] [Related]
12. Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab.
Theeler BJ; Ellezam B; Yust-Katz S; Slopis JM; Loghin ME; de Groot JF
J Neurol; 2014 Aug; 261(8):1559-64. PubMed ID: 24859329
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin Expression and IDH-Wildtype Status Predict Venous Thromboembolism in Patients with High-Grade Gliomas in the Early Postoperative Period.
Watanabe J; Natsumeda M; Okada M; Kanemaru Y; Tsukamoto Y; Oishi M; Kakita A; Fujii Y
World Neurosurg; 2019 Aug; 128():e982-e988. PubMed ID: 31100523
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
15. D-dimer elevation and paresis predict thromboembolic events during bevacizumab therapy for recurrent malignant glioma.
Misch M; Czabanka M; Dengler J; Stoffels M; Auf G; Vajkoczy P; Stockhammer F
Anticancer Res; 2013 May; 33(5):2093-8. PubMed ID: 23645760
[TBL] [Abstract][Full Text] [Related]
16. Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab.
Bahrami N; Piccioni D; Karunamuni R; Chang YH; White N; Delfanti R; Seibert TM; Hattangadi-Gluth JA; Dale A; Farid N; McDonald CR
AJNR Am J Neuroradiol; 2018 Jun; 39(6):1017-1024. PubMed ID: 29622553
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients.
Detti B; Scoccianti S; Teriaca MA; Maragna V; Lorenzetti V; Lucidi S; Bellini C; Greto D; Desideri I; Livi L
Radiol Med; 2021 Sep; 126(9):1249-1254. PubMed ID: 34081269
[TBL] [Abstract][Full Text] [Related]
18. Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.
Desjardins A; Reardon DA; Herndon JE; Marcello J; Quinn JA; Rich JN; Sathornsumetee S; Gururangan S; Sampson J; Bailey L; Bigner DD; Friedman AH; Friedman HS; Vredenburgh JJ
Clin Cancer Res; 2008 Nov; 14(21):7068-73. PubMed ID: 18981004
[TBL] [Abstract][Full Text] [Related]
19. Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.
Diaz M; Jo J; Smolkin M; Ratcliffe SJ; Schiff D
Neurology; 2021 Feb; 96(7):e1063-e1069. PubMed ID: 33361259
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
Zwicker JI; Karp Leaf R; Carrier M
J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
